Geo Fernandos
reacted to
$Bit Brother (BETS.US)$ Lets pull together on this and burn tgem out HARD TOO! This is not a post telling individuals to buy rather telling my fellow investors and future investors TO PROTECT OUR INVESTMENT IN BIT BROTHER theres nothing wrong or illegal about that!! IM CONCERNED ABOUT OUR INVESTMENT AND AS A SHAREHOLDER AMONGST MY FELLOW SHAREHOLDERS WE HAVE A RIGHT TO PROTECT OUR INVESTMENT BY ANY LEGAL FORM OR WAY NEC...
8
6
Geo Fernandos
reacted to
$Centessa Pharmaceuticals (CNTA.US)$ BOSTON and LONDON, Dec. 10, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (NASDAQ:CNTA), today announced new data from an additional 52-weeks of continuous treatment from the third year (Part 5) of the ongoing Phase 2a study of SerpinPC for the treatment of hemophilia. The data were shared in a poster presentation at the American Society of Hematology (ASH) Annual Meeting on Sunday, December 10, 2023. SerpinPC is an investigational subcutaneously...
2
Geo Fernandos
reacted to
$AMC Entertainment (AMC.US)$ the only way shorts can win e.g. the amc battle is to let the stock squeeze lets say up till 700-800 dollars so that the majority of holders will sell their stake…. then the company is for shorts to take… this is my view on this hassle…
7
Geo Fernandos
reacted to
$MAIA Biotechnology (MAIA.US)$ •The lead asset THIO, is the only direct telomere-targeting agent currently in clinical development
• They Recently published preliminary data from the Phase 2 clinical trial THIO-101 with unprecedented disease control and response rates that outperformed the current standard of care
• A impressive Pipeline of immuno-oncology therapies including NSCLC and multiple hard-to-treat cancers with unmet need
• And dont forget a Second-generation te...
• They Recently published preliminary data from the Phase 2 clinical trial THIO-101 with unprecedented disease control and response rates that outperformed the current standard of care
• A impressive Pipeline of immuno-oncology therapies including NSCLC and multiple hard-to-treat cancers with unmet need
• And dont forget a Second-generation te...
3
Geo Fernandos
reacted to
$2seventy bio (TSVT.US)$ SELECTED ABECMA DATA TO BE PRESENTED AT ASH
Oral Presentation: Idecabtagene Vicleucel (ide-cel) Versus Standard Regimens in Patients (pts) with Triple-Class Exposed (TCE) Relapsed and Refractory Multiple Myeloma (RRMM): Updated Analysis from KarMMa-3
Presenter: Paula Rodriguez-Otero
Date & Time: Monday, December 11, 4:45pm PT
In the final progression-free survival (PFS) analysis from the Pha...
Oral Presentation: Idecabtagene Vicleucel (ide-cel) Versus Standard Regimens in Patients (pts) with Triple-Class Exposed (TCE) Relapsed and Refractory Multiple Myeloma (RRMM): Updated Analysis from KarMMa-3
Presenter: Paula Rodriguez-Otero
Date & Time: Monday, December 11, 4:45pm PT
In the final progression-free survival (PFS) analysis from the Pha...
3
13
Geo Fernandos
reacted to
Hi, Canadian traders! ![]()
![]()
Welcome to the moomoo app, where we offer a multitude of features such as analysis tools, trading tutorials, paper trading, and more. We understand that navigating these features at first can be overwhelming, but don't worry. With time, you'll get the hang of it.![]()
However, if you still find yourself struggling or have any suggestions for improving the app, we'd love to hear them. Join the discussion by sharin...
Welcome to the moomoo app, where we offer a multitude of features such as analysis tools, trading tutorials, paper trading, and more. We understand that navigating these features at first can be overwhelming, but don't worry. With time, you'll get the hang of it.
However, if you still find yourself struggling or have any suggestions for improving the app, we'd love to hear them. Join the discussion by sharin...
![Take moomoo from good to great: Imagine being the product manager of our platform](https://ussnsimg.moomoo.com/77777022/editor_image/670d933bd7de34b98ea7fbcac740260b.png/thumb)
23
10